Citations

Mayo Clinic

Showing 10 of 108602 citations.

The safety profile of single antiplatelet therapy with flow diverters: Systematic review and meta-analysis
Şenol, Yiğit Can , Orscelik, Atakan , Ghozy, Sherief , Kobeissi, Hassan , Bilgin, Cem , Kadirvel, Ramanathan , Kallmes, David F. , Arul, Santhosh , Bilgin, Cem , Kadirvel, Ram , Kallmes, David F , Ghozy, Sherief , Kobeissi, Hassan , Orscelik, Atakan , Senol, Yigit Can

Interventional Neuroradiology | April 18, 2023 | Volume: 32 | Issue: 3 | Pages: 732-740

10.1177/15910199231168669 | PMID 37071551 Get It

Background Dual antiplatelet therapy (DAPT) is frequently used in treating cerebral aneurysms with flow diverters (FDs), whereas single antiplatelet therapy (SAPT) is used mostly with coated FDs and in ruptured aneurysms. We conducted a systematic review and meta-analysis to explore the safety profile of SAPT in FDs. Methods PubMed, Web of Science, OVID Embase, OVID Medline, and Scopus were searched to 1st November 2022. Outcomes of interest included ischemic and hemorrhagic complications, conversion to DAPTs, and in-stent stenosis rates under long-term SAPT. SAPT is divided into aspirin (ASA) vs. non-ASA group (ticagrelor or prasugrel). Subgroup analysis was performed for ruptured vs. non-ruptured aneurysms and coated vs. non-coated FDs. All data were analyzed using R software version 4.2.2. Results Twelve studies with 240 total patients (43 patients in the ASA group and 197 patients in the non-ASA group) were included in our meta-analysis. The pooled ischemic occlusion rate was 9.8% (95% CI = 4.87−18.95: p-value = 0.09) for SAPTs. The ASA group had significantly higher ischemic complication rates compared to the non-ASA group (20.8% vs. 6.3%, respectively, p-value = 0.02). The pooled hemorrhagic complication rate was 3.5% (95% CI = 1.38−8.81: p-value > 0.99). The hemorrhagic rates of ASA group were 9.3%% (95% CI = 3.54−22.30) over the non-ASA group 2.1% (95% CI = 0.58−7.54) ( p-value > 0.99). The overall in-stent stenosis rate was 2.3% (95% CI = 1.06−5.14: p-value > 0.99). The ischemic complication rates were comparable between coated vs non-coated FDs (10.7% vs. 5.5% p-value = 0.39). In stent stenosis rate were 1.9% (95% CI = 0.72−4.96) in coated FDs over 4.4% (95% CI = 1.11−16.11) ( p-value = 0.32). The ruptured and non-ruptured groups also showed comparable results in terms of ischemic (17.6% vs. 7.1% respectively, p-value = 0.24) and hemorrhagic complications (9.8% vs. 1.1%, respectively, p-value = 0.08). Conclusions Flow diverter treatment under ASA monotherapy resulted in relatively high ischemic complication rates. However, SAPT with prasugrel or ticagrelor monotherapy is promising for coated FDs and ruptured aneurysm treatments. Given the overall small sample size and also the likely presence of known and unknown biases regarding choice of antiplatelet therapy between groups, larger cohort studies are needed to evaluate SAPT treatment outcomes.
Etiologies and Outcome of Patients with Solid Tumors Admitted to ICU with Acute Respiratory Failure: A Secondary Analysis of the EFRAIM Study
Benguerfi, Soraya , Soares, Márcio , Meert, Anne‐Pascale , Martín‐Loeches, Ignacio , Mehta, Sangeeta , Burghi, Gastón, Kouatchet, Achille, Mokart, Djamel, Louw, Andry Van de , Lemiale, Virginie , group, on behalf of the EFRAIM investigators and Nine-I study, Bauer, Philippe, Martin-Loeches, Ignacio , Dumas, Guillaume , Pène, Frédéric , Bauer, Philippe R. , Metaxa, Victoria , Montini, Luca , Mokart, Djamel , Azoulay, Élie , group, on behalf of the EFRAIM investigators and Nine-I study

Respiratory Care | April 18, 2023 | Volume: 68 | Issue: 6 | Pages: 740-748

10.4187/respcare.10604 | PMID 37072164 Get It

BACKGROUND: Acute respiratory failure (ARF) remains the most frequent reason for ICU admission in patients who are immunocompromised. This study reports etiologies and outcomes of ARF in subjects with solid tumors. METHODS: This study was a post hoc analysis of the EFRAIM study, a prospective multinational cohort study that included 1611 subjects who were immunocompromised and with ARF admitted to the ICU. Subjects with solid tumors admitted to the ICU with ARF were included in the analysis. RESULTS: Among the subjects from the EFRAIM cohort, 529 subjects with solid tumors (32.8%) were included in the analysis. At ICU admission, the median (interquartile range) Sequential Organ Failure Assessment score was 5 (3–9). The types of solid tumor were mostly lung cancer ( n = 111, 21%), breast cancer ( n = 52, 9.8%), and digestive cancer ( n = 47, 8.9%). A majority, 379 subjects (71.6%) were full code at ICU admission. The ARF was caused by bacterial or viral infection ( n = 220, 41.6%), extrapulmonary sepsis ( n = 62, 11.7%), or related to cancer or treatment toxicity ( n = 83, 15.7%), or fungal infection ( n = 23, 4.3%). For 63 subjects (11.9%), the ARF etiology remained unknown after an extensive diagnostic workup. The hospital mortality rate was 45.7% ( n = 232/508). Hospital mortality was independently associated with chronic cardiac failure (odds ratio 1.78, 95% CI 1.09–2.92; P = .02), lung cancer (odds ratio 2.50, 95% CI 1.51–4.19; P < .001), day 1 Sequential Organ Failure Assessment score (odds ratio 1.97, 95% CI 1.32-2.96; P < .001). ARF etiologies other than infectious, related to cancer, or treatment toxicity were associated with better outcomes (odds ratio 0.32, 95% CI 0.16–0.61; P < .001). CONCLUSIONS: Infectious diseases remained the most frequent cause of ARF in subjects with solid tumors admitted to the ICU. Hospital mortality was related to severity at ICU admission, previous comorbidities, and ARF etiologies related to non-malignant causes or pulmonary embolism. Lung tumor was also independently associated with higher mortality.
Clinical Features, Non-Contrast CT Radiomic and Radiological Signs in Models for the Prediction of Hematoma Expansion in Intracerebral Hemorrhage
Chen, Zejia , Zhang, Liying , Carrington, André , Thornhill, Rebecca E. , Miguel, Olivier, Auriat, Angela M. , Omid‐Fard, Nima , Hiremath, Shivaprakash B. , Abitbul, Vered Tshemeister, Morotti, Andrea , Casetta, Ilaria , Fainardi, Enrico , Elkabouli, Marah, Talbot, Zoé, Chen, Zejia Frank , Carrington, André M , Thornhill, Rebecca , Hiremath, Shivaprakash , Tshemeister Abitbul, Vered , Dowlatshahi, Dar , Demchuk, Andrew M. , Gladstone, David J. , Huynh, Thien , Melkus, Gerd , Aviv, Richard Ivan

Canadian Association of Radiologists Journal | April 18, 2023 | Volume: 74 | Issue: 4 | Pages: 713-722

10.1177/08465371231168383 | PMID 37070854 Get It

Purpose Rapid identification of hematoma expansion (HE) risk at baseline is a priority in intracerebral hemorrhage (ICH) patients and may impact clinical decision making. Predictive scores using clinical features and Non-Contract Computed Tomography (NCCT)-based features exist, however, the extent to which each feature set contributes to identification is limited. This paper aims to investigate the relative value of clinical, radiological, and radiomics features in HE prediction. Methods Original data was retrospectively obtained from three major prospective clinical trials [“Spot Sign” Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (SPOTLIGHT)NCT01359202; The Spot Sign for Predicting and Treating ICH Growth Study (STOP-IT)NCT00810888] Patients baseline and follow-up scans following ICH were included. Clinical, NCCT radiological, and radiomics features were extracted, and multivariate modeling was conducted on each feature set. Results 317 patients from 38 sites met inclusion criteria. Warfarin use (p=0.001) and GCS score (p=0.046) were significant clinical predictors of HE. The best performing model for HE prediction included clinical, radiological, and radiomic features with an area under the curve (AUC) of 87.7%. NCCT radiological features improved upon clinical benchmark model AUC by 6.5% and a clinical & radiomic combination model by 6.4%. Addition of radiomics features improved goodness of fit of both clinical (p=0.012) and clinical & NCCT radiological (p=0.007) models, with marginal improvements on AUC. Inclusion of NCCT radiological signs was best for ruling out HE whereas the radiomic features were best for ruling in HE. Conclusion NCCT-based radiological and radiomics features can improve HE prediction when added to clinical features.
Extracorporeal cardiopulmonary resuscitation: A primer for pharmacists
Brown, Caitlin S. , Wieruszewski, Erin D. , Nei, Scott D. , Vollmer, Nicholas , Mattson, Alicia E , Wieruszewski, Patrick M. , Wieruszewski, Patrick M

American Journal of Health-System Pharmacy | April 18, 2023 | Volume: 80 | Issue: 14 | Pages: 889-898

10.1093/ajhp/zxad077 | PMID 37070401 Get It

Abstract Purpose To describe the use of mechanical circulatory support in the setting of cardiac arrest and summarize pharmacists’ role in extracorporeal cardiopulmonary resuscitation (ECPR). Summary ECPR is increasingly used to reduce morbidity and improve mortality after cardiac arrest. ECPR employs venoarterial ECMO, which provides full circulatory perfusion and gas exchange in both adult and pediatric patients in cardiac arrest. After the emergency medicine team identifies potential candidates for ECPR, the ECMO team is consulted. If deemed a candidate for ECPR by the ECMO team, the patient is cannulated during ongoing standard cardiopulmonary resuscitation. A multidisciplinary team of physicians, nurses, perfusionists, pharmacists, and support staff is needed for successful ECPR. Pharmacists play a vital role in advanced cardiac life support (ACLS) prior to cannulation. Pharmacists intervene to make pharmacotherapy recommendations during ACLS, prepare medications, and administer medications as allowed by institutional and state regulations. Pharmacists also provide pharmacotherapy support in the selection of anticoagulation agents, ongoing vasopressor administration during ECMO cannulation, and the optimization of medication selection in the peri-ECPR period. Conclusion With the growing use of ECPR, pharmacists should be aware of their role in medication optimization during ECPR.
Clinical characteristics, management, and outcomes of patients with primary cardiac angiosarcoma: A systematic review
Chambergo‐Michilot, Diego , Sterner, Rosalie M. , Brañez‐Condorena, Ana , Guerra-Canchari, Pedro , Stulak, John M., De la Cruz-Ku, Gabriel , Brañez-Condorena, Ana , Ku, Gabriel De la Cruz

Journal of Cardiovascular and Thoracic Research | April 18, 2023 | Volume: 15 | Issue: 1 | Pages: 1-8

10.34172/jcvtr.2023.30531 | PMID 37342661 Get It

Primary cardiac angiosarcomas (PCA) are highly aggressive malignant heart tumors. Previous reports have shown a poor prognosis regardless of management, and no consensus or guidelines exist. It is necessary to clarify this information since patients with PCA have a short survival. Therefore, we aimed to systematically review clinical manifestations, management, and outcomes. We systematically searched in PubMed, Scopus, Web of Science, and EMBASE. We intended to include cross-sectional studies, case-control studies, cohort studies, and case series that reported clinical characteristics, management, and outcomes of patients with PCA. As a methodological approach, we used the Joanna Briggs Institute Critical Appraisal Checklist for Case Series and the Newcastle-Ottawa Scale for cohorts. We included six studies (five case series, one cohort). The mean/median age ranged from 39 to 48.9 years. Male sex was predominant. The most frequent manifestations were dyspnea (range: 50%-80%), pericardial effusion (29% & 56%), and chest pain (10%-39%). The mean tumor size ranged from 5.8 to 7.2 cm, with the majority of these localized in the right atrium (70-100%). The most common locations of metastasis were the lung (20%-55.6%), liver (10%-22.2%), and bone (10%-20%). Resection (22.9%-94%), and chemotherapy as neoadjuvant or adjuvant (30%-100%) were the most commonly used methods of treatment. Mortality ranged from 64.7% to 100%. PCA often presents late in its course and usually results in poor prognosis. We strongly recommend performing multi-institutional prospective cohorts to better study disease course and treatments to develop consensus, algorithms, and guidelines for this type of sarcoma.
Quantifying lumen diameter in coronary artery stents with high‐resolution photon counting detector CT and convolutional neural network denoising
Koons, Emily K. , Thorne, Jamison E. , Huber, Nathan R. , Chang, Shaojie , Rajendran, Kishore , McCollough, Cynthia H. , Leng, Shuai

Medical Physics | April 18, 2023 | Volume: 50 | Issue: 7 | Pages: 4173-4181

10.1002/mp.16415 | PMID 37069830 Get It

AbstractBackgroundSmall coronary arteries containing stents pose a challenge in CT imaging due to metal‐induced blooming artifact. High spatial resolution imaging capability is as the presence of highly attenuating materials limits noninvasive assessment of luminal patency.PurposeThe purpose of this study was to quantify the effective lumen diameter within coronary stents using a clinical photon‐counting‐detector (PCD) CT in concert with a convolutional neural network (CNN) denoising algorithm, compared to an energy‐integrating‐detector (EID) CT system.MethodsSeven coronary stents of different materials and inner diameters between 3.43 and 4.72 mm were placed in plastic tubes of diameters 3.96–4.87 mm containing 20 mg/mL of iodine solution, mimicking stented contrast‐enhanced coronary arteries. Tubes were placed parallel with or perpendicular to the scanner's z‐axis in an anthropomorphic phantom emulating an average‐sized patient and scanned with a clinical EID‐CT and PCD‐CT. EID scans were performed using our standard coronary computed tomography angiography (cCTA) protocol (120 kV, 180 quality reference mAs). PCD scans were performed using the ultra‐high‐resolution (UHR) mode (120 × 0.2 mm collimation) at 120 kV with tube current adjusted so that CTDIvol was matched to that of EID scans. EID images were reconstructed per our routine clinical protocol (Br40, 0.6 mm thickness), and with the sharpest available kernel (Br69). PCD images were reconstructed at a thickness of 0.6 mm and a dedicated sharp kernel (Br89) which is only possible with the PCD UHR mode. To address increased image noise introduced by the Br89 kernel, an image‐based CNN denoising algorithm was applied to the PCD images of stents scanned parallel to the scanner's z‐axis. Stents were segmented based on full‐width half maximum thresholding and morphological operations, from which effective lumen diameter was calculated and compared to reference sizes measured with a caliper.ResultsSubstantial blooming artifacts were observed on EID Br40 images, resulting in larger stent struts and reduced lumen diameter (effective diameter underestimated by 41% and 47% for parallel and perpendicular orientations, respectively). Blooming artifacts were observed on EID Br69 images with 19% and 31% underestimation of lumen diameter compared to the caliper for parallel and perpendicular scans, respectively. Overall image quality was substantially improved on PCD, with higher spatial resolution and reduced blooming artifacts, resulting in the clearer delineation of stent struts. Effective lumen diameters were underestimated by 9% and 19% relative to the reference for parallel and perpendicular scans, respectively. CNN reduced image noise by about 50% on PCD images without impacting lumen quantification (<0.3% difference).ConclusionThe PCD UHR mode improved in‐stent lumen quantification for all seven stents as compared to EID images due to decreased blooming artifacts. Implementation of CNN denoising algorithms to PCD data substantially improved image quality.
N-acetylcysteine and Reduction of Ischemia-reperfusion Injury in Liver Transplantation
Croome, Kristopher P.

Transplantation | April 18, 2023 | Volume: 107 | Issue: 9 | Pages: 1874-1874

10.1097/tp.0000000000004598 | PMID 37069629 Get It

Biventricular Cardiac Power Reserve in Heart Failure with Preserved Ejection Fraction
Alogna, Alessio , Omar, Massar , Popović, Dejana , Sorimachi, Hidemi, Omote, Kazunori , Reddy, Yogesh N.V. , Nishimura, Rick , Omar, Massar , Pieske, Burkert , Borlaug, Barry A.

European Journal of Heart Failure | April 18, 2023 | Volume: 25 | Issue: 7 | Pages: 956-966

10.1002/ejhf.2867 | PMID 37070138 Get It

ABSTRACT Aims Cardiac and extracardiac abnormalities play important roles in heart failure with preserved ejection fraction (HFpEF). Biventricular cardiac power output (BCPO) quantifies the total rate of hydraulic work performed by both ventricles, suggesting that it may help to identify patients with HFpEF and more severe cardiac impairments to better individualize treatment. Methods and results Patients with HFpEF (n = 398) underwent comprehensive echocardiography and invasive cardiopulmonary exercise testing. Patients were categorized as low BCPO reserve (n = 199, &lt; median of 1.57 W) or preserved BCPO reserve (n = 199). As compared to those with preserved BCPO reserve, those with low reserve were older and leaner, with more atrial fibrillation, higher N-terminal pro-B-type natriuretic peptide levels, worse renal function, more impaired left ventricular (LV) global longitudinal strain, worse LV diastolic function and right ventricular longitudinal function. Cardiac filling pressures and pulmonary artery pressures at rest were higher in low BCPO reserve, but central pressures were similar during exercise to those with preserved BCPO reserve. Exertional systemic and pulmonary vascular resistances were higher and exercise capacity was more impaired in those with low BCPO reserve. Reduced BCPO reserve was associated with increased risk for the composite endpoint of heart failure hospitalization or death over 2.9 (interquartile range 0.9–4.5) years of follow-up (hazard ratio 2.77, 95% confidence interval 1.73–4.42, p &lt; 0.0001). Conclusions Inability to enhance BCPO during exercise is associated with more advanced HFpEF, increased systemic and pulmonary vascular resistance, reduced exercise capacity and increased adverse events in patients with HFpEF. Novel therapies that enhance biventricular reserve merit further investigation for patients with this phenotype.
The Most Cited and Influential Publications Relating to Ice Hockey Since 2000 Focus Primarily on Concussion and Traumatic Brain Injuries
Dulle, Jamie F. , Moore, M. Lane , Brinkman, Joseph C. , Pollock, Jordan R. , Dulle, Donald L., Jenkins, Anna , Chhabra, Anikar , Jenkins, Anna S, Moore, M Lane , Pollock, Jordan Riley , Chhabra, Anikar , Jenkins, Anna S

Arthroscopy, Sports Medicine, and Rehabilitation | April 18, 2023 | Volume: 5 | Issue: 3 | Pages: No page available

10.1016/j.asmr.2023.02.014 | PMID 37388886 Get It

Purpose To determine the most frequently cited articles relating to ice hockey since 2000 and conduct a bibliometric analysis of these publications. Methods The Clarivate Web of Knowledge database was used to gather data and generate a list of publications relating to “ice hockey” on June 20, 2022. Articles were filtered by the total number of citations accrued and were included or excluded on the basis of relevance to ice hockey; no date of publication, language, or journal restrictions. After the 50 most highly cited articles were identified, articles published before the year 2000 were excluded to avoid bias. The information analyzed from each article included author name (first and last), publication year, country of origin, institutional affiliation (of the first and last author), journal name, research design, main research topic, competition level, and the level of evidence. Results Ultimately, 46 studies were included in this analysis. The total number of citations was 8,267 times with an average of 179.7 citations per article. The most cited article was cited 926 times. The articles came from 5 different countries, with the United States and Canada comprising 27 and 13 articles, respectively. All articles were published in English. The American Journal of Sports Medicine published the greatest number of articles. The most studied topic was concussion/traumatic brain injury (n = 26). Professional hockey was the most studied level of competition (n = 15), while college followed (n = 13). Three institutions, University of Calgary, Dartmouth School of Medicine, and University of North Carolina at Chapel Hill were responsible for 32.6% of the top articles (n = 15). Conclusions The majority of the most cited articles relating to ice hockey are cohort studies, review articles, and epidemiological studies originating from the United States or Canada. The majority of publications included in the analysis focused on concussion and traumatic brain injury prevalence, identification, diagnosis, outcomes, and prevention, as well as the most studied level of competition was professional, but the greatest number of participants arose from the youth and high school level. Level of Evidence Level IV, cross‐sectional study
Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: Back to stage 0?
Brunaldi, Vitor , Oliveira, Guilherme Henrique Peixoto de , Kerbage, Anthony , Ribas, Pedro Henrique Boraschi Vieira, Nunes, Felipe, Faria, Galileu , Riccioppo, Daniel , Santo, Marco Aurélio , Moura, Eduardo Guimarães Hourneaux de , Brunaldi, Vitor Ottoboni , Peixoto de Oliveira, Guilherme Henrique , de Moura, Diogo , de Moura, Eduardo

Endoscopy International Open | April 17, 2023 | Volume: 11 | Issue: 05 | Pages: E538-E545

10.1055/a-2075-1198 | PMID 37251791 Get It

Abstract Background and study aims Significant weight regain affects up to one-third of patients after Roux-en-Y gastric bypass (RYGB) and demands treatment. Transoral outlet reduction (TORe) with argon plasma coagulation (APC) alone or APC plus full-thickness suturing TORe (APC-FTS) is effective in the short term. However, no study has investigated the course of gastrojejunostomy (GJ) or quality of life (QOL) data after the first post-procedure year. Patients and methods Patients eligible for a 36-month follow-up visit after TORe underwent upper gastrointestinal endoscopy with measurement of the GJ and answered QOL questionnaires (RAND-36). The primary aim was to evaluate the long-term outcomes of TORe, including weight loss, QOL, and GJ anastomosis (GJA) size. Comparisons between APC and APC-FTS TORe were a secondary aim. Results Among 39 eligible patients, 29 returned for the 3-year follow-up visit. There were no significant differences in demographics between APC and APC-FTS TORe groups. At 3 years, patients from both groups regained all the weight lost at 12 months, and the GJ diameter was similar to the pre-procedure assessment. As to QOL, most improvements seen at 12 months were lost at 3 years, returning to pre-procedure levels. Only the energy/fatigue domain improvement was kept between the 1- and 3-year visits. Conclusions Obesity is a chronic relapsing disease. Most effects of TORe are lost at 3 years, and redilation of the GJA occurs. Therefore, TORe should be considered iterative rather than a one-off procedure.